The combination of AZD6244 with PD-L1 blockade starting at 3 weeks after syngeneic tumor implantation showed a marked synergistic reduction in 344SQ KP lung tumor growth and metastases that lasted for 8–9 weeks, compared with monotherapy or vehicle/isotype controls (Fig. 2a). Here, CD274 is linked to neoplasm.